To assess the effectiveness of intra-tympanic dexamethasone on the frequency and severity of attacks of vertigo, on chronic symptoms such as tinnitus, imbalance and hearing loss, and on the progression of these symptoms in patients with definite meniere’s disease or syndrome, as defined by the AAO-HNS Committee.We also use electrocochleography (ECOG) for evaluation of hydrops before and after of injection.
Materials and Metods :A prospective cohort study including 25 adult patients of a tertiary referral ENT clinic whom definite , unilateral meniere's patients and non responsive to medical treatment was selected. also they had no piror ear surgery or other medical comorbidity.
Baseline ECOG obtained , treatment with 4 mg ( IT-Dex) , ( 3 doses totally &with a week interval) was carried out.
We recorded Post treatment ECOG, one month after 3rd ( IT-Dex) injection , and evaluated clinical sign 6 to 12 months after treatment.
General information
Acronym
IRCT registration information
IRCT registration number:IRCT2014050112691N2
Registration date:2014-12-08, 1393/09/17
Registration timing:registered_while_recruiting
Last update:
Update count:0
Registration date
2014-12-08, 1393/09/17
Registrant information
Name
Nasrin Yazdani
Name of organization / entity
Tehran univesity of Medical Sciences, Amir Alam Hospital
Country
Iran (Islamic Republic of)
Phone
+98 21 6676 0269
Email address
n_yazdani@sina.tums.ac.ir
Recruitment status
Recruitment complete
Funding source
Tehran University of Medical Science
Expected recruitment start date
2013-02-28, 1391/12/10
Expected recruitment end date
2014-12-31, 1393/10/10
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Evaluation of intra-tympanic dexamethasone with alterations of electrocochleography in meniere's patients.
Public title
Evaluation of intra-tympanic dexamethasone in meniere disease
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Definite meniere ; Age beyond 18 years; NOresponse to medical mangment
Exclusion criteria:
Musculoskeletal disease ; Spinal cord disease; Middle ear disease ; Addiction ;Usage of ototoxic drugs